CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea
Youngji Jo, Sun Bean Kim, Munkhzul Radnaabaatar, Kyungmin Huh, Jin-Hong Yoo, Kyong Ran Peck, Hojun Park, Jaehun Jung
Epidemiol Health. 2022;44:e2022034  Published online March 12, 2022
DOI: https://doi.org/10.4178/epih.e2022034

Excel Download

Antivirals based on nanomaterials against SARS-CoV-2
Biomedical Innovations to Combat COVID-19. 2022;271-305   Crossref logo
Link1 Link2

Antivirals against SARS-CoV-2 by autumn?
BMJ. 2021;n1215   Crossref logo
Link1 Link2

Safety and efficacy of antivirals against SARS-CoV-2
BMJ. 2021;n2611   Crossref logo
Link1 Link2

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
The Lancet Infectious Diseases. 2022;22(8):e231-e238   Crossref logo
Link1 Link2

Bioinformatic analysis of epitope-based vaccine design against the novel SARS-COV-2
. 2020;   Crossref logo
Link1 Link2

Virtual Screening of Some Antivirals That Can Be Repurposed As Potential Effective Drugs against SARS-CoV-2
. 2020;   Crossref logo
Link1

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
Frontiers in Microbiology. 2022;13:   Crossref logo
Link1

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
Vaccines. 2020;8(2):335   Crossref logo
Link1

Virtual Screening of Some Antivirals That Can Be Repurposed As Potential Effective Drugs against SARS-CoV-2
. 2020;   Crossref logo
Link1

New Potential Drug Candidates Against SARS-CoV-2 Using Generative Model
. 2021;   Crossref logo
Link1